Keytruda (pembrolizumab) - Merck (MSD)
VTP-600 - Barinthus Bio
https://oncologypro.esmo.org/congress-resources/esmo-immuno-oncology-congress-2025?presentation=preliminary_peripheral_immunogenicity_of_a_mage_a3
 
M.I. Gomez-Randulfe Rodriguez1; A. Samson2; D.P. Hadjiyiannakis3; S. Ahmed4; I. Karydis5; N.A. Coupe6; N. Steele7; D. Joseph-Pietras8; D. Gear9; G. morsiani9; H. Lavender9; A. Karamani10; V. Spanswick10; L.W. Hooftman11; B.J. van den Eynde12; C. Leung13; A. Hill13; M.R. Middleton14; S.N. Symeonides15; F. Blackhall1
 
Oct 27, 2025
 
Prev Next